Sctc-online.org
Title
Scleroderma Clinical Trials Consortium
Description
About SCTC
The Scleroderma Clinical Trials Consortium (SCTC) is a charitable non-profit organization dedicated to finding better treatment for scleroderma. Member institutions of the SCTC conduct clinical treatment trials of new (and sometimes old) medications that appear promising for the treatment of scleroderma. The SCTC was started in 1994 with a handful of members and has now grown to an international membership of over 50 centers in the U.S., Canada, the U.K., and Europe. An annual meeting is held in conjunction with the annual American College of Rheumatology meeting in the Fall of the year. The next business meeting of the SCTC will take place on Sunday, October 17th, 2004 from 6:30 to 8:30pm, The San Antonio Riverwalk Marriott Hotel.
In addition, members of the SCTC have organized to set up trials of their own, with funding from organizations like the Scleroderma Foundation, the U.S. FDA (Federal Drug Administration), and the National Institutes of Health (NIH) to study some medications already on the market but not approved for scleroderma.
The SCTC also supports research to establish standard outcome measures for clinical treatment trials so that results can be compared over time and over different patient groups.
Contact
- Center for Rheumatic Diseases
-
- Boston MA
- United States 02118
-
- +1.6176384310
